2016 marked a banner year for our company. We are humbled by the loyalty of our ever-expanding client roster. At the same time, we take great pride in what we’ve accomplished over the last 12 months and we’d like to share some of those endeavors with you here. If you’re new to Hayes, or not yet a member, we invite you to view just a sample of the innovation and growth we’ve experienced as an indication of things to come.
So without further ado…
Genetic Test Evaluation (GTE) Program Launches the Indication Report
You asked. We listened. With the plethora of available genetic tests, payers and providers struggled to determine, without bias, which genetic tests had clinical utility. We introduced the Indication report in August of this year as a means to save payers and providers precious time and resources by performing the “deep dive” for them. The development process included industry research, market surveys, and discussions with you, our clients. The reports, along with the other product offerings in the GTE program, better enable evidence-based decisions regarding the ordering and reimbursement of the right test, for the right patient, at the right time.
Review of Reviews
2016 also saw the addition of the Review of Reviews to the Medical Technology Directory. The Reviews are themselves comprehensive health technology assessments (HTAs). However, they focus on broad-based topics using existing, high-quality systematic reviews and HTAs from the peer-reviewed, published literature to assess the benefits and harms of health technologies (devices, drugs, biologics, tests, or treatments). Resources include PubMed, Embase, and Cochrane Library, among others. Clients can request reviews of topics that are broader in scope (i.e. evidence comparisons for cardiac stents) with a rapid turnaround, saving them valuable time when a coverage decision is needed quickly.
Inaugural Hayes Client Symposium
After more than 25 years in business, on September 23rd, we held our very first (and long overdue) Client Symposium. Payer clients from all over the country attended a day of lectures (including some accredited for CEUs) and peer networking. We met our subscribers face-to-face, many for the first time, and some who have been with us for more than two decades. We talked, and not just about what we did well. We laughed. And we ate. Oh, did we eat!
You can read more about the symposium on our blog here. If you didn’t make it for this first event, don’t worry, as it wasn’t the last. Keep an eye here for news of the 2017 Symposium, coming soon.
The Year’s Most Viewed Reports
We’re proud of our ability to provide you with fiercely unbiased, thoroughly scrutinized evidence. But were you aware that each year, we also produce more reports than our closest competitor? 2016 was no exception. Across our product lines, in addition to almost daily feeds from our News Service, our diligent and hard-working teams published nearly 600 reports. That’s a staggering number; one with which we’re quite delighted. We hope you were, too.
It should come as no surprise that the top 10 most-viewed reports were all from our Genetic Test Evaluation (GTE) program. That impressive statistic is a testament to the quality of our cutting-edge product and the value you, our subscribers, have placed upon it.
The GTE program will continue to expand in 2017. If you haven’t included the GTE program to your current Hayes subscription, there’s no time like the present. Schedule a demo today.
More to Come
The advances don’t stop here. We have an aggressive growth plan for 2017 and beyond, with the goal of not just bringing you the products and services you’ve come to expect, but to exceed your expectations. We’ve got our eye on the future for you (see our blog “5 Health Technologies to Watch in 2017), and we hope to see both new and familiar faces.
Best wishes for a happy and healthy holiday season!